Cyclosporine NDC 10702-808

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-808Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0808Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
10702-808-03	10702080803	30 VIAL, SINGLE-USE in 1 TRAY (10702-808-03) / .4 mL in 1 VIAL, SINGLE-USEMarketed from Feb 10, 2022
10702-808-06	10702080806	60 VIAL, SINGLE-USE in 1 TRAY (10702-808-06) / .4 mL in 1 VIAL, SINGLE-USEMarketed from Feb 10, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cyclosporine
Generic name (nonproprietary): cyclosporine
Active ingredients: Cyclosporine — .5 mg/mL
Dosage form: Emulsion
Route: Ophthalmic
Labeler: KVK-TECH, INC.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050790
Marketing start: Feb 10, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Calcineurin Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 10702-808_795f036f-ee97-42b7-bd36-fff9220ce428SPL ID 795f036f-ee97-42b7-bd36-fff9220ce428SPL set ID a7040dc6-063b-40ee-8f2a-153e87b08430RxCUI 2572292UNII 83HN0GTJ6DUPC 0310702808034, 0310702808065
Pharmacologic class: Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702080803 followed by a unit qualifier and the quantity

Package 10702-0808-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 23, 2024.

Indications (excerpt from the label)

Cyclosporine ophthalmic emulsion, 0.05% is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs. Cyclosporine ophthalmic emulsion, 0.05% is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or u…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050790

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050790
Product	Strength	Form · route	Labeler	Product NDC
Restasiscyclosporine	Cyclosporine .5 mg/mL	EmulsionOphthalmic	A-S Medication Solutions	50090-4476
Cyclosporine	Cyclosporine .5 mg/mL	EmulsionOphthalmic	Lupin Pharmaceuticals, Inc.	68180-214
Cyclosporine	Cyclosporine .5 mg/mL	EmulsionOphthalmic	Apotex Corp	60505-6202
Restasiscyclosporine	Cyclosporine .5 mg/mL	EmulsionOphthalmic	Allergan, Inc.	0023-9163
Restasis MultiDosecyclosporine	Cyclosporine .5 mg/mL	EmulsionOphthalmic	Allergan, Inc.	0023-5301